Key facts
- It has raised $22.0M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Plug and Play Tech Center, Accenture Ventures, Pitango Venture Capital, Bertelsmann Investments, Atooro Fund — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for QuantHealth
- ·The full record, as it builds
Funding rounds
No funding rounds for QuantHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About QuantHealth
Developer of artificial intelligence-based drug development data software designed to conduct patient-centric drug simulations to accelerate and de-risk drug development. The company's software combines data points from across the clinical and drug development spectrum and predicts patient response to both approved and novel therapies, allowing pharma and biotech customers to run variations of their clinical trials to improve the trial design and increase the probability of trial success, enabling healthcare industry in the discovery of new clinical opportunities and improve strategies.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2020
- Employees
- 60
- Website
- quanthealth.ai/
- Ownership
- Privately Held (backing)
QuantHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in QuantHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on QuantHealth in its N-PORT filings yet. We sweep new filings monthly.